×
Hero Background

Hirsutism Treatment Companies

ID: MRFR/HC/2570-HCR
200 Pages
Rahul Gotadki
October 2025

Hirsutism is a condition characterized by the excessive growth of coarse and dark hair in areas where men typically grow hair, such as the face, chest, and back, in women. The treatment of hirsutism often involves addressing the underlying cause, such as hormonal imbalances, and may include pharmaceutical interventions. 

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Hirsutism Treatment Market

Hirsutism Treatment Market

 


Latest Hirsutism Treatment Companies Updates:


Elnora Pharmaceuticals Inc. (US) Received FDA approval for its VIOKAL™ (elagolix), a once-daily oral medication for the treatment of moderate-to-severe hirsutism in women with androgen excess (Jan 2024).


Bayer AG (Germany) Announced positive Phase 3 data for its investigational oral androgen receptor antagonist (OAR), KAE-779, for the treatment of hirsutism in women with PCOS (Dec 2023).


Lutronic Corporation (South Korea) Launched its SpectraLite Versa™ IPL hair removal system for professional and home use, offering a safe and effective option for managing unwanted hair growth associated with hirsutism (Nov 2023).


Candela Corporation (US) Introduced its GentleMax Pro Plus® laser system with advanced features for permanent hair reduction, catering to the growing demand for minimally invasive hirsutism treatments (Oct 2023).


List of Hirsutism Treatment Key companies in the market:



  • AbbVie Inc. (US)

  • Allergan (Republic of Ireland)

  • Bayer AG (Germany)

  • Bristol-Myers Squibb Company (US)

  • Jubilant Cadista (US)

  • Pfizer Inc. (US)

  • Sun Pharmaceutical Industries Ltd. (India)